Income Statement (TTM)
IGC Pharma, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -35.47 | 6.15 | -56.46 | -17.65 | 10.56 | 11.52 | 34.01 | 27.44 | 27.88 | 5.07 | 37.65 | 7.10 | -9.46 | 10.61 | -21.04 | 11.39 | 4.48 | 2.83 | 4.41 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Change (%) | -37.64 | 5.51 | -62.04 | -27.18 | -6.45 | 0.00 | 9.36 | 22.07 | 54.98 | 11.67 | 49.04 | 7.15 | -21.09 | 3.55 | -31.21 | 23.04 | 15.83 | 8.67 | 9.97 | |
| % of Revenue | 91.00 | 87.94 | 87.42 | 76.21 | 67.39 | 57.02 | 51.13 | 41.73 | 39.97 | 48.44 | 51.48 | 55.74 | 55.77 | 48.60 | 45.50 | 39.64 | 43.79 | 48.54 | 51.30 | 54.03 |
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -13.56 | 10.78 | -17.70 | 12.90 | 45.71 | 26.80 | 59.79 | 31.29 | 9.83 | -1.12 | 25.57 | 7.03 | 5.22 | 17.28 | -12.55 | 3.74 | -4.36 | -2.67 | -1.45 | |
| % of Revenue | 9.00 | 12.06 | 12.58 | 23.79 | 32.61 | 42.98 | 48.87 | 58.27 | 60.03 | 51.56 | 48.52 | 44.26 | 44.23 | 51.40 | 54.50 | 60.36 | 56.21 | 51.46 | 48.70 | 45.97 |
| SG&A | 7 | 8 | 8 | 8 | 11 | 10 | 12 | 12 | 10 | 9 | 9 | 9 | 8 | 8 | 7 | 7 | 6 | 6 | 4 | 4 |
| Change (%) | 11.26 | 3.56 | 0.27 | 33.13 | -1.10 | 19.34 | -1.81 | -18.76 | -6.06 | -8.40 | 0.90 | -4.65 | 0.21 | -18.04 | 0.25 | -5.15 | -6.27 | -26.78 | -9.95 | |
| % of Revenue | 523.49 | 902.60 | 880.62 | 2,027.88 | 3,278.26 | 2,932.58 | 3,138.29 | 2,299.44 | 1,465.78 | 1,076.82 | 938.75 | 688.12 | 612.66 | 678.04 | 502.45 | 637.95 | 543.20 | 487.30 | 346.97 | 299.25 |
| R&D | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Change (%) | -14.34 | 10.33 | 23.90 | 4.95 | 18.46 | 62.82 | 40.77 | 15.00 | 11.37 | -17.61 | -18.69 | 17.77 | 2.93 | 10.61 | 3.76 | -8.97 | -1.43 | 4.04 | -1.04 | |
| % of Revenue | 74.98 | 99.53 | 103.45 | 294.37 | 375.16 | 401.97 | 586.90 | 616.54 | 556.34 | 484.54 | 379.91 | 224.40 | 246.76 | 280.51 | 280.52 | 368.64 | 301.27 | 284.22 | 287.57 | 272.57 |
| OpEx | 9 | 9 | 10 | 9 | 12 | 12 | 15 | 16 | 14 | 14 | 12 | 12 | 12 | 12 | 11 | 11 | 11 | 10 | 9 | 8 |
| Change (%) | 2.02 | 4.34 | -2.54 | 27.76 | 0.78 | 24.17 | 4.96 | -11.15 | -0.17 | -10.57 | -2.72 | 1.23 | -0.36 | -9.01 | -0.29 | -5.43 | -3.54 | -14.00 | -4.73 | |
| % of Revenue | 689.47 | 1,090.07 | 1,071.49 | 2,398.47 | 3,720.81 | 3,391.57 | 3,776.32 | 2,957.71 | 2,062.09 | 1,609.80 | 1,370.14 | 968.26 | 915.19 | 1,007.15 | 828.48 | 1,046.23 | 888.25 | 820.06 | 685.84 | 625.85 |
| Operating Income | -8 | -8 | -9 | -9 | -12 | -12 | -15 | -15 | -13 | -13 | -12 | -11 | -11 | -11 | -10 | -10 | -9 | -9 | -7 | -7 |
| Change (%) | 8.39 | 4.15 | 3.01 | 29.73 | 0.51 | 24.55 | 4.17 | -12.50 | -1.60 | -11.60 | -5.90 | 0.55 | 0.76 | -11.18 | 2.56 | -7.20 | -4.56 | -16.34 | -6.29 | |
| % of Revenue | -589.47 | -990.07 | -971.49 | -2,298.47 | -3,620.81 | -3,291.57 | -3,676.32 | -2,857.71 | -1,962.09 | -1,509.80 | -1,270.14 | -868.26 | -815.19 | -907.15 | -728.48 | -946.23 | -788.25 | -720.06 | -585.84 | -525.85 |
| Interest Expense | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| Net Income | -8 | -9 | -9 | -9 | -11 | -11 | -15 | -16 | -14 | -14 | -12 | -11 | -11 | -14 | -13 | -13 | -13 | -9 | -7 | -6 |
| Change (%) | 8.68 | -2.27 | -1.07 | 30.82 | 0.51 | 31.01 | 6.64 | -11.88 | -0.94 | -17.69 | -6.17 | 0.08 | 30.91 | -8.09 | 2.33 | -5.52 | -29.91 | -19.16 | -10.94 | |
| % of Revenue | -632.80 | -1,065.72 | -981.18 | -2,229.41 | -3,541.61 | -3,219.66 | -3,782.37 | -3,009.96 | -2,081.27 | -1,612.34 | -1,263.01 | -860.93 | -804.54 | -1,163.24 | -966.54 | -1,252.64 | -1,062.47 | -712.70 | -560.27 | -477.92 |
Source: Capital IQ
